Abstract
Multiple modalities of cognitive stimulation (CS) have been designed and tested in samples of patients with probable Alzheimer’s disease (AD). Despite the substantial inter-study variability, an overall positive impact of CS is reported. This impact has been especially observed in general measures of cognition. The mechanisms by which cognitive exercises would be beneficial for high-order cortical functions are still largely undetermined, however. When CS has been applied to patients with mild cognitive impairment (who are at the prodromal stage of AD) more stringent methodological criteria and designs were used and studies have been of greater clinical and research relevance. At this disease stage, a positive impact of CS has been reported in a range of different cognitive domains, and even at a neuro-computational level by the measurement of test-retest modifications of brain function. The effects of CS in healthy adults have also been studied. This population allows researchers to explore and test specific neural mechanisms possibly underlying the effect of pen-and-paper or computerised exercises. The evidence from these studies and those contributing to a better understanding of the pathophysiology of AD has led to devising forms of CS as preventive and therapeutical measures for neurodegenerative diseases based on novel frameworks of brain structure, function and connectivity. An extensive review of the literature was carried out to clarify whether CS is effective in AD and mild cognitive impairment and, together with the evidence from studies in healthy participants, to identify the relevant mechanisms that might sustain this effectiveness.
Keywords: Alzheimer’s disease, cognitive stimulation, cognitive training, mild cognitive impairment, neural changes, nonpharmacological treatment.
Current Alzheimer Research
Title:Cognitive Stimulation: The Evidence Base for its Application in Neurodegenerative Disease
Volume: 11 Issue: 5
Author(s): Matteo De Marco, Michael F. Shanks and Annalena Venneri
Affiliation:
Keywords: Alzheimer’s disease, cognitive stimulation, cognitive training, mild cognitive impairment, neural changes, nonpharmacological treatment.
Abstract: Multiple modalities of cognitive stimulation (CS) have been designed and tested in samples of patients with probable Alzheimer’s disease (AD). Despite the substantial inter-study variability, an overall positive impact of CS is reported. This impact has been especially observed in general measures of cognition. The mechanisms by which cognitive exercises would be beneficial for high-order cortical functions are still largely undetermined, however. When CS has been applied to patients with mild cognitive impairment (who are at the prodromal stage of AD) more stringent methodological criteria and designs were used and studies have been of greater clinical and research relevance. At this disease stage, a positive impact of CS has been reported in a range of different cognitive domains, and even at a neuro-computational level by the measurement of test-retest modifications of brain function. The effects of CS in healthy adults have also been studied. This population allows researchers to explore and test specific neural mechanisms possibly underlying the effect of pen-and-paper or computerised exercises. The evidence from these studies and those contributing to a better understanding of the pathophysiology of AD has led to devising forms of CS as preventive and therapeutical measures for neurodegenerative diseases based on novel frameworks of brain structure, function and connectivity. An extensive review of the literature was carried out to clarify whether CS is effective in AD and mild cognitive impairment and, together with the evidence from studies in healthy participants, to identify the relevant mechanisms that might sustain this effectiveness.
Export Options
About this article
Cite this article as:
Marco De Matteo, Shanks F. Michael and Venneri Annalena, Cognitive Stimulation: The Evidence Base for its Application in Neurodegenerative Disease, Current Alzheimer Research 2014; 11 (5) . https://dx.doi.org/10.2174/1567205011666140505120145
DOI https://dx.doi.org/10.2174/1567205011666140505120145 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Alzheimer's Disease Drug Development
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Despite decades of research, no cure or disease-modifying treatment is available yet. Therefore, the need for developing effective therapies to treat Alzheimer's disease is an urgent matter. This special issue aims to provide a comprehensive overview of ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science Mechanisms Involved in BACE Upregulation Associated to Stress
Current Alzheimer Research Synthesis, Molecular Targets, and Antitumor Activities of Substituted Tetrahydro-1- Oxopyrano[4,3-b][1]Benzopyrans and Nanogels for Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry The Complement Cascade: New Avenues in Stroke Therapy
Current Vascular Pharmacology The Role of Malnutrition in Older Persons with Mobility Limitations
Current Pharmaceutical Design Nanomedicines for Brain Targeting: A Patent Review
Recent Patents on Nanomedicine Oral Supplements of <i>Ginkgo biloba</i> Extract Alleviate Neuroinflammation, Oxidative Impairments and Neurotoxicity in Rotenone-Induced Parkinsonian Rats
Current Pharmaceutical Biotechnology Design, Synthesis and Characterization of Novel Urolithin Derivatives as Cholinesterase Inhibitor Agents
Letters in Drug Design & Discovery Mitochondrial Dysfunction and Alzheimers Disease
Current Alzheimer Research The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Fish Oil has Beneficial Effects on Behavior Impairment and Oxidative Stress in Rats Subjected to a Hepatic Encephalopathy Model
CNS & Neurological Disorders - Drug Targets Pharmacological Properties of Physical Exercise in The Elderly
Current Pharmaceutical Design The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors
Current Topics in Medicinal Chemistry 5-ht6 Receptors
Current Drug Targets - CNS & Neurological Disorders Treatment of Mild Cognitive Impairment (MCI)
Current Alzheimer Research Targeting Tau Hyperphosphorylation <I>via</I> Kinase Inhibition: Strategy to Address Alzheimer's Disease
Current Topics in Medicinal Chemistry Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks
Current Diabetes Reviews Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews